Comparison of EMR and ESD for early Barrett's neoplasia: A Systematic Review and Meta-Analysis
Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S214-S215
DOI: 10.1055/s-0044-1783181 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von K. Khalaf und 10 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Aims
Barrett's esophagus (BE) with visible lesions including high-grade dysplasia and esophageal adenocarcinoma is treated by endoscopic resection. Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) are both accepted strategies for resection of Barrett’s lesions. However, a lack of consensus exists regarding which technique offers superior clinical outcomes and safety. This study aims to compare the clinical outcomes and safety of EMR versus ESD in treating early Barrett's neoplasia and esophageal adenocarcinoma.
Methods
We searched 3 databases (Embase, MEDLINE, Cochrane Central) until October 1st, 2023. We included studies aimed at assessing the efficacy of EMR and ESD as treatment modalities for BE and esophageal adenocarcinoma. Our inclusive criteria encompassed randomized trials as well as observational studies. We focused on key outcome measures, namely, en bloc , R0 and curative resection rates, recurrence rates and adverse events rates. We performed meta-analyses on reported rates for en bloc , R0 and curative resection, and recurrence. Effect sizes were expressed as pooled Odds Ratio (OR) and 95% Confidence Intervals (CI) for resection and recurrence rates, and 95% Confidence Intervals (CI).
Results
Our search identified 905 records. We excluded 181 duplicates, screened 22 full texts and 724 abstracts from the total search. 15 studies were included in the final analyses. Data pooled from 11 studies showed significantly higher en bloc resection rates [OR=1.846 (95% CI: 1.567-2.125), 11 studies] with ESD. R0 resection rates from 10 studies were significantly higher with ESD [OR=1.58, (95% CI: 0.955-2.21), 10 studies]. Curative resection rates from 5 studies were significantly higher with ESD [OR=1.173 (95% CI: 0.066 – 2.280), 5 studies]. The local recurrence rates pooled from 10 studies were significantly higher with EMR [OR=0.941 (95% CI: 0.129-1.753), 10 studies].
Conclusions
In a systematic review of studies comparing EMR and ESD for early Barrett's neoplasia, ESD achieves higher en bloc , R0 and curative resection rates, while EMR is associated with higher local recurrence rates. These results suggest that ESD may be a more effective option for managing early Barrett's neoplasia. [ 1 ] [ 2 ] [ 3 ] [ 4 ] [ 5 ] [ 6 ] [ 7 ] [ 8 ] [ 9 ] [ 10 ] [ 11 ] [ 12 ] [ 13 ] PROSPERO: (CRD42023426486) Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Khalaf, K., Fujiyoshi, Y., He, T., Tham, D., Yuhong, Y., Fujiyoshi, M. A., Gimpaya, N., Calo, N., Grover, S., May, G., & Teshima, C. (2024). Comparison of EMR and ESD for early Barrett's neoplasia: A Systematic Review and Meta-Analysis. Endoscopy, 56(S 02 S 02), S214-S215. https://doi.org/10.1055/s-0044-1783181
Vancouver
Khalaf K, Fujiyoshi Y, He T, Tham D, Yuhong Y, Fujiyoshi MA, et al. Comparison of EMR and ESD for early Barrett's neoplasia: A Systematic Review and Meta-Analysis. Endoscopy. 2024;56(S 02 S 02):S214-S215. doi:10.1055/s-0044-1783181
BibTeX
@article{Khalaf2024,
author = {Khalaf, K. and Fujiyoshi, Y. and He, T. and Tham, D. and Yuhong, Y. and Fujiyoshi, M.R. A. and Gimpaya, N. and Calo, N. and Grover, S. and May, G. and Teshima, C.},
title = {Comparison of EMR and ESD for early Barrett's neoplasia: A Systematic Review and Meta-Analysis},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 02 S 02},
pages = {S214--S215},
doi = {10.1055/s-0044-1783181}
}
EUVIMED